Global Pharmaceutical Intermediates Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2027
"Global Pharmaceutical Intermediates Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2027" is a recent report generated by MarketResearch.biz, which offers in-depth insights, revenue details, and other vital information regarding the global pharmaceutical intermediates market, and the various trends, drivers, restraints, opportunities, and threats in the target market till 2027. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global pharmaceutical intermediates market report has been segmented on the basis of product type, application, distribution channel, and region.
Active pharmaceutical ingredient is a substance that is intended to supply pharmacological activity or other direct effect in diagnosis, cure, mitigation, treatment, or prevention of disease. Pharmaceutical intermediates are chemical compounds that are building blocks used in production of active pharmaceutical ingredients. Pharmaceutical intermediates are produced during process of manufacturing or synthesis of active pharmaceutical ingredients. These pharmaceutical intermediates further undergo molecular changes and processing before becoming an active pharmaceutical ingredient.
Increasing prevalence of various diseases across the globe is a major factors driving growth of the global pharmaceutical intermediates market. In addition, increasing government expenditure on pharmaceuticals sector in developing countries, coupled with rising research and development activities for development of new innovative and advanced products are other factors expected to support growth of the global market over the forecast period.
Moreover, rising disposable income, changing lifestyle patter which is results in increasing number of people suffering from various diseases, and rising number of geriatric population prone to various diseases are some other major factors increasing demands for various medicine, which in turn is expected to support growth of the target market. Furthermore, increasing demand for generic drug is expected to boost production of active pharmaceutical ingredients which in turn is expected to further drive growth of the market to certain extent.
However, stringent regulations related to product approval is a major factor expected to hamper growth of the market to certain extent.
Technological advancements and increasing R&D activities by major players for novel products offerings is expected to create new opportunities in terms of revenue for players operating in the target market over the forecast period. In addition, growing public private partnership in developing countries is expected to create revenue opportunities which is expected to support growth of the market to certain extent.
The market in North America is expected to dominate the global market and is expected to continue its dominance over the forecast period. This can be attributed to well-developed pharmaceutical sector and presence of major manufacturers in the countries in this region. Asia Pacific is expected to witness faster growth, owing to increasing government expenditure on pharmaceutical sector, growing merger and acquisition activities among regional and international players in emerging economies in this region. In 2017, according to India Brand Equity Foundation, India exported pharmaceutical products worth US$ 16.89 Bn. The market in Europe is expected to contribute significant revenue share in the global market.
Global Pharmaceutical Intermediates Market Segmentation:
By Product Type:
- Non GMP
- Antipyretic analgesics
By Distribution Channel:
- Direct Sales
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Particular Scope Region
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- South Africa
- Rest of Middle East and Africa
Actual Year 2017 Estimated Year 2018 Forecast Period 2018–2027 Revenue in US$
- Aceto Corporation
- Easter Chemical Corporation
- BASF SE
- Midas Pharma GmbH
- R. Life Sciences Private Limited
- Lianhe Chemical Technology Co Ltd.
- Dishman Pharmaceuticals and Chemicals Limited
- Codexis, Inc.
- Sanofi Winthrop Industrie S.A.
- Vertellus Holdings LLC
- Dextra Laboratories Limited,
- Chemcon Specialty Chemical Pvt. Ltd.
- ZCL Chemical Ltd.
Request for TOC
Request for Customization
Don't just take our word. We are trusted by these great companies!